Founded in 2001, Strategic Medicine is committed to improving the quality and effectiveness of healthcare through the research, development and implementation of its proprietary patient and disease stratification models.

One Size Doesn't Fit All

The company addresses a fundamental problem in medicine – the old diagnostic categories are becoming more inadequate by the day, and one-size-fits all drug therapies lead to costly late stage failures and withdrawals. Many attempts to solve these issues by providing simplified personalized medicine are unrealistic in the marketplace and misguided in their scientific underpinnings.

Improving Outcomes through Better Patient and Disease Stratification

Strategic Medicine’s mission is to improve clinical outcomes through better patient and disease stratification. The company addresses a fundamental problem in medicine that is increasingly problematic for patients, healthcare providers, and payers alike.

SMI offers disease stratification products and services driven by clinical need and supported by its rapidly expanding knowledge base and improved implementation of diagnostic technology.

Directly Interact with Electronic Medical Records

These products sit on top of, and interact directly will existing electronic medical records (EMR). They can also function as stand-alone systems and are accessible by patients through their healthcare providers. SMI continues to develop disease stratification products and services driven by clinical need and supported by its rapidly expanding knowledge base and improved implementation of diagnostic technology.

SMI works with patient advocacy groups, disease foundations, and pharmaceutical clinical trials groups to establish better guidelines for therapy and care, and develop better predictors of outcome. And all these are implemented in the company’s model systems.